I'll research KKR before writing the preview. Let me gather recent earnings materials, filings, and news.I have the key documents. Let me read the most recent earnings materials (2026Q1) and the year-ago quarter (2025Q2) for context, plus recent news.I have rich detail from the Q1 2026 report and call. Let me pull recent stock performance and any additional Q2-relevant context.I now have what I need. Here's the preview.
KKR heads into this print with its operating fundamentals still compounding at ~20% but its stock cut roughly in half from its 2025 highs — so the report is less about the headline beat/miss and more about whether management can restore confidence in the monetization outlook it walked back last quarter, and calm the market's fears around insurance competition and private credit.
The single most important piece of context is the stock. KKR traded as high as ~$152 in late July 2025 and bottomed near $88 in late February 2026 before clawing back to ~$101 into this print — leaving it down ~33% year-over-year. That drawdown badly lagged peers over the same window (Blackstone ~-26%, Apollo ~-18%).
Yet the fundamentals told a very different story. In Q1 2026 (reported May 5), KKR posted: - FRE of $1.13/share, +23% y/y (FRE margin ~69%) - Total Operating Earnings of $1.47/share, +18–19% y/y - Adjusted Net Income of $1.39/share, +20–21% y/y - AUM of $758B (+14% y/y), FPAUM $615B (+17%), perpetual capital $326B (43% of AUM)
Management leaned hard into this disconnect — literally overlaying the stock chart on multi-year FRE/TOE/ANI charts on the Q1 call — and both co-CEOs and multiple directors bought stock personally. That framing ("don't trust the headlines") is the backdrop; this quarter is the test of whether the numbers keep validating it.
What the Street expects Thursday: total AUM growth of ~15% to ~$788B and EPS around $1.43 for the quarter, per pre-print sentiment. Broad Street view is constructive long-term but nervous near-term on (a) monetizations and (b) insurance competition.
This is the crux. Entering 2026, KKR guided to "$7+ ANI/share," implying ~45% y/y growth, assuming a "constructive and normalized" monetization environment. On the Q1 call, CFO Rob Lewin explicitly walked that back: given a "more challenging" first four months, if you're handicapping it, "more likely… below $7."
Nuances to hold in mind when you read the release and listen to the call: - Management framed this as timing, not magnitude — delayed monetizations shift to 2027+, not lost. Scott Nuttall's point: they don't want to sell great assets into an uncertain (war/energy) backdrop. - The offsetting bull signal: Q1 gross monetization revenue was up >50% y/y (~$880M), realized carry +120% y/y, and the forward monetization pipeline of $1.2B+ was the highest they'd ever disclosed on a call.
What to watch Thursday: - Realized performance income and realized investment income (the swing factors for ANI). - Any refreshed language on the full-year ANI trajectory — does "below $7" firm up to a range, and does the forward monetization figure grow again? - Embedded gains ($18.3B firm-wide, gross unrealized carry $10.2B at 3/31) — a rising number reinforces the "value is there, it's just timing" thesis. - Realizations already flagged/announced (OneStream at 4.5x, CoolIT ~15x, Hyundai Marine Solutions ~7x, plus two 2021-vintage exits) — watch how much lands in Q2.
FRE is the highest-quality, most-valued earnings stream, and it has been the reliable engine. Watch: - Management fees (were $1.2B in Q1, +30% y/y, or +20%+ ex-catch-up) and whether the ~69% FRE margin holds. - Fundraising cadence. KKR raised $28B in Q1 and $127B LTM, notably diversified (PE/real assets/credit each ~1/3 of fees). Management flagged it expects a Q2 slowdown, echoing the post-tariff pattern of a year ago — so a soft fundraising number may be pre-signaled, not a negative surprise. - K-Series (wealth): $38B AUM at 3/31 (+80% y/y) with only ~$250M of redemptions. Given the sector-wide noise around wealth/private-credit redemptions, this is a sentiment lightning rod — watch the redemption figure closely. - Fund launches in the pipeline that feed future fees: Asia PE, Europe PE, tech/health-care growth, Global Infra, and the Capital Group partnership products.
The most cited near-term worry alongside monetizations. On the Q1 call, management acknowledged elevated competition on the liability side and very tight asset spreads, which pressured ROEs and led KKR to pull back on retail origination. Insurance operating earnings were ~$260M (or slightly north of $300M including marks; run-rate ~$330M at target returns).
What to watch: - The trajectory of Insurance Operating Earnings and any commentary on spreads — management said late in Q1 that wider spreads were creating a more attractive entry point, so Q2 could mark an inflection or continued pressure. - The "total insurance economics" figure (was $1.9B LTM, +14%) on page 22 of the release — the fuller picture of GA's contribution. - Reminder of the optionality: $6B of dry-powder equity → ~$60B+ of liability buying power if volatility creates dislocation.
Broader market anxiety about private credit is a key reason the multiple compressed. KKR pre-empted this in Q1 by adding disclosure showing direct lending is only ~5% of AUM ($39B) and private BDCs <0.5% ($3B), with consistent outperformance versus benchmarks across vintages. Notably, management said institutions were coming back to direct lending in recent weeks, viewing the dislocation as an attractive entry point, while ABF (>$90B) remains the larger, higher-momentum engine.
Watch: any update on credit fundraising (Q1 was one of the largest non-GA credit quarters at $15B), redemption trends, and FSK/BDC commentary. Reassurance here could be a meaningful sentiment unlock.
With the stock near multi-year lows, KKR leaned into repurchases — $317M at ~$91/share through May 1, plus a $500M authorization increase and an auto-replenishing program structure. Given the stock spent Q2 largely in the $90s (dipping to ~$89 in late June), the size of Q2 buybacks will be a direct read on how cheap management thinks its own shares are. The four capital-allocation levers to track: strategic M&A, insurance, buybacks, and Strategic Holdings.
Also monitor Strategic Holdings — reaffirmed at $350M+ operating earnings for 2026 (back-end weighted), stepping to $700M+ by 2028 and $1.1B+ by 2030. Progress here supports the "durable, growing recurring earnings" narrative (85% of LTM segment earnings are recurring).
Q2 was active on the deployment side, which supports future fees and carry but also uses capital: - DCC Energy: KKR/Energy Capital Partners consortium won acceptance for an improved takeover valued up to ~£5.8B (~$7.85B), with a firm ~£5.75B deal agreed by July 27. Watch for confirmation and financing color; note some large DCC holders (Fidelity, Aviva, Ninety One) had argued the bid undervalued the company. - SK Inc. renewables JV: a $1.3B clean-power platform targeting AI data-center/semiconductor demand — fits the digital-infrastructure/energy theme. - Arctos (~$16B AUM sports/GP-solutions franchise) closed May 5 — first quarter of contribution (embedded in PE line); watch for any commentary on the "$100B+ solutions business" ambition.
Analysts pressed on AI risk in Q1 (software ~7% of AUM; ~15% within PE) and on Strategic Holdings' business-services concentration. Expect more of the same. Management's stance: net beneficiary via digital-infrastructure deployment (>$40B, 20%+ gross IRR) and portfolio value creation across 150+ companies. Any hard KPIs on AI-driven EBITDA uplift would be new and well-received.
Bullish scenario: FRE keeps compounding ~20%+, the forward monetization pipeline grows again (firming the case that "$7-ish" is deferred not destroyed), wealth redemptions stay negligible, and insurance spreads show signs of inflecting — all while buybacks stay aggressive. That combination directly attacks the perception-vs.-fundamentals gap management has been hammering.
Bearish scenario: softer monetizations with no pipeline offset, further ANI trimming, continued insurance ROE pressure, or any uptick in wealth/credit redemptions — which would validate the multiple compression and keep the stock range-bound.
Net: After a ~33% derating, expectations are modest and sentiment is defensive, so the bar to positively surprise is arguably low. The key tells will be the forward monetization figure, any refresh of the full-year ANI framing, insurance spread commentary, and the pace of buybacks — not the ~$1.43 headline EPS itself.
Note: All company financials referenced are from KKR's Q1 2026 earnings release/call (reported May 5, 2026); Q2 Street expectations and deal items are from pre-print news through July 27, 2026; stock levels are from daily closing prices. Figures are as management reported them and are not independently verified for this preview.